Biotech Horizon Pharma Files To Sell Up To $86.3 Million In IPO
Biotech Horizon Pharma Files To Sell Up To $86.3 Million In IPO
Read more on FOX Business
In a presentation entitled: Systems Medicine and Emerging Technologies: Catalyzing a Transformation from a Reactive to a Proactive (P4) Medicine (predictive, personalized, preventive and participatory), Dr Hood outlines the Systems Biology Institutes ultimate goal of enhancing peoples lives by using the science of systems biology to predict, prevent, and cure disease. As the ability to garner huge amounts of data about our bodies and the environment becomes cheaper and more commonplace, this may become the new basis for medical care. Learn why the SCImago Group rated the Institute for Systems Biologys papers as having the most scientific impact in the USA and third highest worldwide. A Montana native and recipient of both the Lasker and Kyoto prizes, Dr. Hood has 17 honorary degrees (including one from MSU). He also holds a George R. Stibitz award from the Bozeman American Computer Museum, and has founded 14 biotechnology companies.
Powered by Yahoo! Answers
